SULFASALAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfasalazine, and when can generic versions of Sulfasalazine launch?
Sulfasalazine is a drug marketed by Nuvo Pharms Inc, Watson Labs, Chartwell, Epic Pharma Llc, Sun Pharm Industries, and Superpharm. and is included in ten NDAs.
The generic ingredient in SULFASALAZINE is sulfasalazine. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfasalazine
A generic version of SULFASALAZINE was approved as sulfasalazine by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFASALAZINE?
- What are the global sales for SULFASALAZINE?
- What is Average Wholesale Price for SULFASALAZINE?
Summary for SULFASALAZINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 142 |
| Clinical Trials: | 100 |
| Drug Prices: | Drug price information for SULFASALAZINE |
| What excipients (inactive ingredients) are in SULFASALAZINE? | SULFASALAZINE excipients list |
| DailyMed Link: | SULFASALAZINE at DailyMed |
See drug prices for SULFASALAZINE
Recent Clinical Trials for SULFASALAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | Phase 3 |
| Cairo University | Phase 3 |
| Rutgers, The State University of New Jersey | Phase 2 |
Pharmacology for SULFASALAZINE
| Drug Class | Aminosalicylate |
Medical Subject Heading (MeSH) Categories for SULFASALAZINE
Anatomical Therapeutic Chemical (ATC) Classes for SULFASALAZINE
US Patents and Regulatory Information for SULFASALAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuvo Pharms Inc | SULFASALAZINE | sulfasalazine | TABLET, DELAYED RELEASE;ORAL | 075339-001 | Jan 11, 2002 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Superpharm | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 089339-001 | Oct 26, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Epic Pharma Llc | SULFASALAZINE | sulfasalazine | TABLET;ORAL | 086184-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
